Skip to content

OS Therapies OSTX APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition

APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition at other companies

CTO
Citius Oncology, Inc.CTOR
$3.53M+68.9%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's apic, share-based payment arrangement, option, increase for cost recognition.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's APIC, share-based payment arrangement, option, increase for cost recognition?
OS Therapies (OSTX) reported APIC, share-based payment arrangement, option, increase for cost recognition of $1.44M in Q1 2026.
How has OS Therapies's APIC, share-based payment arrangement, option, increase for cost recognition changed year-over-year?
OS Therapies's APIC, share-based payment arrangement, option, increase for cost recognition increased by 52.5% year-over-year, from $941.28K to $1.44M.
What does APIC, share-based payment arrangement, option, increase for cost recognition mean?
This reflects the non-cash expense recognized for share-based compensation, such as stock options or restricted stock units, over the requisite service period. It is an accounting adjustment that increases additional paid-in capital without a direct cash outflow. It is a critical component for understanding the true cost of employee and director compensation.